GALMED PHARMACEUTICALS LTD. (EOCN) Free cash flow 2016–2024
GALMED PHARMACEUTICALS LTD. (EOCN) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.9MFY2024 · since FY2016: -$12.9M → -$5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$5.9M | +4.3% |
| FY2023 | -$6.1M | +66.8% |
| FY2022 | -$18.5M | +43.6% |
| FY2021 | -$32.9M | -24.7% |
| FY2020 | -$26.4M | -76.4% |
| FY2019 | -$14.9M | -65.4% |
| FY2018 | -$9.0M | +26.1% |
| FY2017 | -$12.2M | +5.2% |
| FY2016 | -$12.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice